Figure 3From: Protease inhibitor associated mutations compromise the efficacy of therapy in human immunodeficiency virus – 1 (HIV-1) infected pediatric patients: a cross-sectional studyAssociation of drug-specific HIV-1 mutations and plasma viral load (PVL).Back to article page